-
CAR T for Large Tumors: The Next Frontier?
contractpharma
September 12, 2019
Traditional cancer treatments tend to be unprecise, the effect of which both healthy and cancerous cells are destroyed. Chemotherapy or radiation are like the military carpet bombing an area...
-
Personalised cell therapy developer Achilles closes £100m round
pharmaceutical-technology
September 05, 2019
UK-based Achilles Therapeutics has announced the closing of its £100m Series B financing round, which was led by new investor RA Capital Management and founding investor Syncona.
-
Warning issued to company for selling unapproved stem cell products
europeanpharmaceuticalreview
September 05, 2019
A warning has been issued to Stemell for manufacturing and distributing unapproved products derived from umbilical cord blood.
-
Study shows the potential to deliver immunotherapy directly to brain tumours
europeanpharmaceuticalreview
September 02, 2019
New nano-immunotherapy has traversed the blood-brain barrier in mice, inducing an immune response in brain tissue surrounding tumours.
-
Interactions discovered in cells insulating nerve pathways
worldpharmanews
August 29, 2019
Schwann cells form a protective sheath around nerve fibres and ensure that nerve impulses are transmitted rapidly.
-
Mustang Bio, CSL Behring Enter License Agreement for Stable Producer Cell Line
contractpharma
August 28, 2019
Cytegrity™ is a stable producer cell line developed by St. Jude Children’s Research Hospital for the treatment of X-linked severe combined immunodeficiency.
-
Preventing tumor metastasis
worldpharmanews
August 23, 2019
Researchers at the Paul Scherrer Institute, together with colleagues from the pharmaceutical company F. Hoffmann-La Roche AG...
-
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies
b3cnewswire
August 22, 2019
Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI)...
-
Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing
b3cnewswire
August 13, 2019
Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions.
-
Giant Cell Arteritis Occurs at Similar Rate in Blacks, Whites
drugs
August 12, 2019
Biopsy-proven giant cell arteritis (BP-GCA) occurs at a similar rate among white and black patients, according to a study published online in JAMA Ophthalmology.